J&J may not meet US COVID-19 vaccine supply target by spring: NYT
Johnson & Johnson is facing unexpected delays in the manufacturing of its coronavirus vaccine and may not be able to supply the doses it promised the federal government by spring, the New York Times reported on Wednesday.
US federal officials have been told that J&J has fallen as much as two months behind the original production schedule and will not catch up until the end of April, when it was supposed to have delivered more than 60 million doses, the NYT reported, citing people familiar with the situation.
The company and the US Department of Health and Human Services did not immediately respond to Reuters requests for comment.
Earlier this week, J&J’s chief executive officer said the company was on track to have close to a billion COVID-19 vaccine doses by 2021-end.
(Source: Reuters)
FBI chief: Chinese hackers targeting critical US infrastructure
Pro-Palestine rallies spread after students arrested at Columbia University
US police arrest 108 pro-Palestine protesters at Columbia University
The struggles of Occupied Palestine
Ayatollah Khamenei exalts great Persian poet on Saadi Day
Iran’s Civil Defense examines country’s preparation for potential threats
FBI chief: Chinese hackers targeting critical US infrastructure
New York Times leaked memo on Gaza coverage reveals obfuscation of facts
VIDEO | Press TV's news headlines
Barbados officially announces recognition of Palestine as state
US Senate reauthorizes surveillance bill despite privacy concerns
This makes it easy to access the Press TV website
